392 related articles for article (PubMed ID: 22522289)
41. Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.
de Almeida SM; Bhatt A; Riggs PK; Durelle J; Lazzaretto D; Marquie-Beck J; McCutchan A; Letendre S; Ellis R
J Neurovirol; 2010 Feb; 16(1):6-12. PubMed ID: 20132081
[TBL] [Abstract][Full Text] [Related]
42. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.
Mukerji SS; Misra V; Lorenz D; Cervantes-Arslanian AM; Lyons J; Chalkias S; Wurcel A; Burke D; Venna N; Morgello S; Koralnik IJ; Gabuzda D
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):246-255. PubMed ID: 28328546
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
44. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.
Bingham R; Ahmed N; Rangi P; Johnson M; Tyrer M; Green J
Int J STD AIDS; 2011 Oct; 22(10):608-9. PubMed ID: 21998185
[TBL] [Abstract][Full Text] [Related]
45. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
[TBL] [Abstract][Full Text] [Related]
46. Etravirine concentrations in CSF in HIV-infected patients.
Tiraboschi JM; Niubo J; Vila A; Perez-Pujol S; Podzamczer D
J Antimicrob Chemother; 2012 Jun; 67(6):1446-8. PubMed ID: 22357802
[TBL] [Abstract][Full Text] [Related]
47. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States.
Mukerji SS; Misra V; Lorenz DR; Uno H; Morgello S; Franklin D; Ellis RJ; Letendre S; Gabuzda D
Clin Infect Dis; 2018 Sep; 67(8):1182-1190. PubMed ID: 29617912
[TBL] [Abstract][Full Text] [Related]
48. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.
Peluso MJ; Ferretti F; Peterson J; Lee E; Fuchs D; Boschini A; Gisslén M; Angoff N; Price RW; Cinque P; Spudich S
AIDS; 2012 Sep; 26(14):1765-74. PubMed ID: 22614889
[TBL] [Abstract][Full Text] [Related]
49. CSF, plasma viral load and HIV associated dementia.
Robertson K; Fiscus S; Kapoor C; Robertson W; Schneider G; Shepard R; Howe L; Silva S; Hall C
J Neurovirol; 1998 Feb; 4(1):90-4. PubMed ID: 9531015
[TBL] [Abstract][Full Text] [Related]
50. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
Pérez-Valero I; Ellis R; Heaton R; Deutsch R; Franklin D; Clifford DB; Collier A; Gelman B; Marra C; McCutchan JA; Navis A; Sacktor N; Simpson D; Grant I; Letendre S
AIDS; 2019 Mar; 33(3):475-481. PubMed ID: 30702516
[TBL] [Abstract][Full Text] [Related]
51. HIV Type 1 replication in cerebrospinal fluid of patients with AIDS-related non-Hodgkin's lymphoma receiving chemotherapy and antiretroviral therapy.
Giancola ML; Uccella I; Alba L; Lorenzini P; Soldani F; Capobianchi M; Ruco L; Perno CF; Antinori A
AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1091-5. PubMed ID: 14709245
[TBL] [Abstract][Full Text] [Related]
52. HIV encephalitis in a patient on antiretroviral therapy: a case report.
Hlebowicz M; Parczewski M; Jakubowski P
Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
[TBL] [Abstract][Full Text] [Related]
53. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
[TBL] [Abstract][Full Text] [Related]
54. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.
Aweeka F; Jayewardene A; Staprans S; Bellibas SE; Kearney B; Lizak P; Novakovic-Agopian T; Price RW
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):39-43. PubMed ID: 9928728
[TBL] [Abstract][Full Text] [Related]
55. Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma.
Haas DW; Clough LA; Johnson BW; Harris VL; Spearman P; Wilkinson GR; Fletcher CV; Fiscus S; Raffanti S; Donlon R; McKinsey J; Nicotera J; Schmidt D; Shoup RE; Kates RE; Lloyd RM; Larder B
AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1491-502. PubMed ID: 11054262
[TBL] [Abstract][Full Text] [Related]
56. The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.
Hammond ER; Crum RM; Treisman GJ; Mehta SH; Marra CM; Clifford DB; Morgello S; Simpson DM; Gelman BB; Ellis RJ; Grant I; Letendre SL; McArthur JC;
Am J Epidemiol; 2014 Aug; 180(3):297-307. PubMed ID: 24966216
[TBL] [Abstract][Full Text] [Related]
57. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.
Staprans S; Marlowe N; Glidden D; Novakovic-Agopian T; Grant RM; Heyes M; Aweeka F; Deeks S; Price RW
AIDS; 1999 Jun; 13(9):1051-61. PubMed ID: 10397535
[TBL] [Abstract][Full Text] [Related]
58. Clinical factors related to brain structure in HIV: the CHARTER study.
Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I;
J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705
[TBL] [Abstract][Full Text] [Related]
59. Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin.
Price RW; Parham R; Kroll JL; Wring SA; Baker B; Sailstad J; Hoh R; Liegler T; Spudich S; Kuritzkes DR; Deeks SG
Antivir Ther; 2008; 13(3):369-74. PubMed ID: 18572749
[TBL] [Abstract][Full Text] [Related]
60. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.
Patton SM; Wang Q; Hulgan T; Connor JR; Jia P; Zhao Z; Letendre SL; Ellis RJ; Bush WS; Samuels DC; Franklin DR; Kaur H; Iudicello J; Grant I; Kallianpur AR
Fluids Barriers CNS; 2017 Apr; 14(1):11. PubMed ID: 28427421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
